Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Mark E. Jones, PhD

Basilea Pharmaceutica International Ltd., Allschwil, Switzerland, Switzerland

Disclosure(s): Basilea Pharmaceutica International Ltd: Employee, Stocks/Bonds (Public Company)

Poster(s):

(P-1526) In vitro Activity of Ceftobiprole Against Prominent Methicillin-resistant Staphylococcus aureus Clonal Groups Collected Through the SENTRY Antimicrobial Surveillance Program

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
(P-1527) Update on the Activity of Ceftobiprole against Gram-positive Clinical Bacterial Isolates Causing Skin and Skin-structure Infections in the United States (2016–2020).

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT